Lewisville, Texas (January 2, 2018) – BayMark Health Services, a portfolio company of Webster Capital and national provider of opioid treatment services, announced today that it has merged with Healthcare Resource Centers (HCRC), a leading independent OTP provider in the Northeastern U.S. with 15 facilities that serves over 6,500 patients a day.
BayMark CEO, Dave White, remarked, “The professionals at Healthcare Resource Centers have a reputation of delivering exceptional patient care and that drew us to this opportunity.” Webster Co-Managing Partner, David Malm, said, “With the state of opioid abuse in the United States, BayMark is focused on providing care throughout the country, and the Northeast is one of the most impacted areas.”
“When we began to look for an organization to assume the management of our treatment programs, we knew fairly quickly that BayMark was the right fit to continue the mission that we have established.” said Edward Blain, M.Ed., and Chief Executive Officer of Health Care Resource Centers. “Their focus on not only the well-being of the patients, but also the well-being of the staff, ensured that our legacy will be maintained and enhanced under their leadership.”
BayMark has expanded into 26 states and is one of the largest opioid treatments companies in the United States. Webster invested in BayMark in 2015 with the goal of providing care to those impacted by opioid abuse.
About BayMark Health Services
BayMark Health Services, headquartered in Lewisville, Texas, is a specialty health care organization whose core business is to provide evidence-based treatment services for opioid addiction and dependency with 95 treatment locations in 26 states, treating over 30,000 patients daily in their recovery from opioid addiction. BayMark’s outpatient programs provide medically supervised treatment for addiction to prescription pain medications and other opioids; offering a selection of medication treatment options and counseling services in a wide variety of settings focused on meeting the individual needs of our patients. Our continuum of programs currently include treatment with methadone and buprenorphine in highly structured Opioid Treatment Programs (OTPs), treatment with buprenorphine in less structured office based settings (OBOT), and medically supervised detoxification combined with Vivitrol or longer term injectable implants. For further information, please visit www.baymark.com.
About Webster Capital
Founded in 2003, Webster Capital is a private equity partnership which helps companies unlock their potential. Webster focuses on branded consumer and healthcare services companies with EBITDA between $3 million to $15 million. Webster Capital provides equity financing, expertise, and a broad contact network for management buyouts and growth capital. Webster has raised $600 million and is currently investing Fund III, a $400 million fund raised in 2014. For additional information on Webster Capital, please visit www.webstercapital.com.